Reduced postprandial glycaemia by 39-50% in healthy subjects and type 2 diabetes. Reduced postprandial insulin excursion by ~25% in type 2 diabetes. Does not involve additional energy intake. The gene discussed is INS; the disease is type 2 diabetes mellitus.